跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOSTATIN 100 microgram/1mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
SANDOSTATIN 100 microgram/1mL injection ampoule
Approved
STANDARD
SANDOSTATIN 100 microgram/1mL injection ampoule
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6cfd8b76103283b3
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6cfd8b76103283b3
Product Name
SANDOSTATIN 100 microgram/1mL injection ampoule
Artg Id
42193
Artg Name
SANDOSTATIN Octreotide 100 microgram/1mL injection ampoule
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
1993-01-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d592e8d3f54d0ba01e6d9630bad85c43.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/021c94453992bff98624b24a86c6553e.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6cfd8b76103283b3
Type
Standard
Back to TGA Approvals
